Leukemia & Lymphoma, Volume 60, Issue 14 (2019)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 60, Issue 14 (2019)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Volume 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
Biosimilar drugs: how safe are they?
Silvia Montoto
Pages: 3343-3344
Published online: 21 Aug 2019
CitationforBiosimilar drugs: how safe are they? | Full Text | References | PDF (238.7 KB) | EPUB
  • 98 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Beware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma
Luis F. Porrata
Pages: 3345-3346
Published online: 26 Sep 2019
CitationforBeware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphoma | Full Text | References | PDF (239.4 KB) | EPUB
  • 96 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
For CLL cells, there’s no place like home
Benjamin L. Lampson & Jennifer R. Brown
Pages: 3347-3349
Published online: 02 Aug 2019
First Page PreviewforFor CLL cells, there’s no place like home | Full Text | References | PDF (303.9 KB) | EPUB
  • 165 Views
  • 1 CrossRef citations
  • 0Altmetric

Reviews

Review
Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics
David A. Knorr, Aaron D. Goldberg, Eytan M. Stein & Martin S. Tallman
Pages: 3350-3362
Published online: 23 Jul 2019
AbstractforImmunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeutics | Full Text | References | PDF (1.3 MB) | EPUB
  • 680 Views
  • 2 CrossRef citations
  • 0Altmetric
Review
Neutropenia and leukemia development: genetic risk factors and prognosis
Saeid Shahrabi, Mohsen Maleknia, Yousef Tavakolifar, Zeinab D. Zayeri & Najmaldin Saki
Pages: 3363-3374
Published online: 19 Jun 2019
AbstractforNeutropenia and leukemia development: genetic risk factors and prognosis | Full Text | References | PDF (1.5 MB) | EPUB
  • 333 Views
  • 8 CrossRef citations
  • 0Altmetric

Original Articles

Article
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study
Myrna Candelaria, Derlis E. González, Marcia Torresan Delamain, Daniel Oscar Bär, Surender Kumar Beniwal, Lokanatha Dasappa, David Hugo Flores, John Querol, Toh See Guan, Oleg Nikolaevich Lipatov, Elena Mikhailovna Volodicheva, Moosa Patel, Sayyed Reza Safaee Nodehi, Laura Fogliatto, Alexandra Paravisini, Luis Perez Diaz & on behalf of the RTXM83 study
Pages: 3375-3385
Published online: 04 Jul 2019
AbstractforRituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 5120 Views
  • 18 CrossRef citations
  • 0Altmetric
Open Access
Article
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)
Ombretta Annibali, Stefan Hohaus, Francesco Marchesi, Maria Cantonetti, Alice Di Rocco, Valeria Tomarchio, Arianna Di Napoli, Sabrina Pelliccia, Roberta Battistini, Paola Anticoli Borza, Elisabetta Abruzzese, Natalia Cenfra, Alessandro Andriani, Cristiano Tesei, Eleonora Alma, Francesca Palombi, Livio Pupo, Luigi Petrucci, Marco Becilli, Elena Maiolo, Silvia Bellesi, Annarosa Cuccaro, Francesco D’Alò & Maria Christina Cox
Pages: 3386-3394
Published online: 01 Jul 2019
AbstractforThe neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) | Full Text | References | PDF (1.3 MB) | EPUB
  • 200 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment
Isacco Ferrarini, Antonella Rigo, Alberto Zamò & Fabrizio Vinante
Pages: 3395-3405
Published online: 14 Jul 2019
AbstractforClassical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 305 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study
Soon Khai Low, Ahmad Helmy Zayan, Obaida Istanbuly, Minh Duc Nguyen Tran, Amr Ebied, Gehad Mohamed Tawfik & Nguyen Tien Huy
Pages: 3406-3416
Published online: 19 Jul 2019
AbstractforPrognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based study | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 246 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western Australia
James A. Kuzich, Andrew P. Hutchison, Kenneth J. C. Lim, Portia Smallbone, Kate Denning, Matthew P. Wright, Gavin Cull, Michael F. Leahy, David J. L. Joske, Dejan Radeski & Duncan Purtill
Pages: 3417-3425
Published online: 15 Jul 2019
AbstractforPrognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western Australia | Full Text | References | PDF (778.1 KB) | EPUB
  • 227 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base
Thomas A. Ollila, John L. Reagan & Adam J. Olszewski
Pages: 3426-3433
Published online: 09 Jul 2019
AbstractforClinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data Base | Full Text | References | PDF (1 MB) | EPUB
  • 655 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma
Junko Yamaguchi, Yoshiaki Chinen, Tomoko Takimoto-Shimomura, Hiroaki Nagata, Ayako Muramatsu, Kodai Kuriyama, Muneo Ohshiro, Yoshiko Hirakawa, Toshiki Iwai, Hitoji Uchiyama, Nobuhiko Uoshima, Hiroto Kaneko, Mitsushige Nakao, Taku Tsukamoto, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Isao Yokota, Junya Kuroda & KOTOSG Investigators
Pages: 3434-3441
Published online: 18 Jul 2019
AbstractforPrediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma | Full Text | References | PDF (716.3 KB) | EPUB
  • 432 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital
Andrés González-García, José Luis Patier de la Peña, Mónica García-Cosio, Yasmina Sarhane, Cristina Sánchez Díaz, Ignacio Barbolla Díaz, Mónica López Rodríguez, María Ángeles Moreno, Jesús Villarubia & Luis Manzano
Pages: 3442-3448
Published online: 15 Jul 2019
AbstractforClinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospital | Full Text | References | PDF (2 MB) | EPUB
  • 180 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivors
Estherina Trachtenberg, Ronit Gurion, Tatiana Mashiach, Tamar Tadmor, Meirav Kedmi & Eldad J. Dann
Pages: 3449-3454
Published online: 22 Jul 2019
AbstractforRecognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivors | Full Text | References | PDF (638.7 KB) | EPUB | Supplemental
  • 330 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia – lessons for immunopathogenesis and prescribing
Zaal Meher-Homji, Constantine S. Tam, Jim Siderov, John Francis Seymour, Natasha E. Holmes, Kyra Y. L. Chua, Elizabeth J. Phillips, Monica A. Slavin & Jason A. Trubiano
Pages: 3455-3460
Published online: 01 Jul 2019
AbstractforHigh prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia – lessons for immunopathogenesis and prescribing | Full Text | References | PDF (1.4 MB) | EPUB
  • 310 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia
Leslie A. Andritsos, John C. Byrd, Peter Cheverton, Jingyang Wu, Mariela Sivina, Thomas J. Kipps & Jan A. Burger
Pages: 3461-3469
Published online: 27 Jul 2019
AbstractforA multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemia | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 510 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis
Ziren Chen, Wei Mai, Zhengxiong Li, Haoyang Zhang, Yu Zheng, Shunrong Hong, Wencong Yang, Weiliang Xiao, Zhilin Chen & Shuncong Wang
Pages: 3470-3481
Published online: 15 Jul 2019
AbstractforThe epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysis | Full Text | References | PDF (2.4 MB) | EPUB | Supplemental
  • 229 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol
Renato Bassan, Monica Fumagalli, Sabina Chiaretti, Ernesta Audisio, Nicola Cascavilla, Stefania Paolini, Mario Delia, Elisa Cerqui, Caterina Micò, Francesco Fabbiano, Martina Canichella, Anna Maria Scattolin, Paola Perfetti, Francesca Paoloni, Mariangela Iodice, Antonella Vitale, Irene Della Starza, Paola Fazi, Marco Vignetti & Robin Foà
Pages: 3482-3492
Published online: 12 Jul 2019
AbstractforPhase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocol | Full Text | References | PDF (1.3 MB) | EPUB
  • 307 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available
Lynda Foltz, Gian-Matteo Pica, Hacene Zerazhi, Jan Van Droogenbroeck, Sorin Visanica, Enrique Báez de la Fuente, Brian Leber, Antonio Medina de Almeida, Dana Ranta, Jean-Jacques Kiladjian, Linda Chrit, Albert Kandra, Juliane Morando & Timothy Devos
Pages: 3493-3502
Published online: 30 Jul 2019
AbstractforSafety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available | Full Text | References | PDF (997.8 KB) | EPUB | Supplemental
  • 906 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments
Guangying Sheng, Mengxing Xue, Qinrong Wang, Lijun Wen, Suning Chen, Xinyou Zhang & Xiaofei Yang
Pages: 3503-3511
Published online: 08 Jul 2019
AbstractforOccurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatments | Full Text | References | PDF (1.6 MB) | EPUB
  • 161 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia
Jason N. Barreto, Michael W. Cullen, Kristin C. Mara, Meagan E. Grove, Amanda G. Sierzchulski, Nathan J. Dahl, Pritish K. Tosh, Ross A. Dierkhising, Mrinal M. Patnaik & Michael J. Ackerman
Pages: 3512-3520
Published online: 12 Jul 2019
AbstractforQT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia | Full Text | References | PDF (1.4 MB) | EPUB
  • 620 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation
Kaito Harada, Takayoshi Tachibana, Kazuteru Ohashi, Yukiyasu Ozawa, Masashi Sawa, Tadakazu Kondo, Jun Ishikawa, Makoto Onizuka, Kazunori Imada, Tomoaki Fujisaki, Junji Tanaka, Takahiro Fukuda, Yoshiko Atsuta & Shinichi Kako
Pages: 3521-3528
Published online: 10 Jul 2019
AbstractforThe effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantation | Full Text | References | PDF (753.5 KB) | EPUB | Supplemental
  • 207 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
HIV portends a poor prognosis in myelodysplastic syndromes
Justin D. Kaner, Santiago Thibaud, Sakshi Jasra, Yanhua Wang, Murali Janakiram, Anjali Sharma, Ashwin Sridharan, Harold Elias, Rahul Polineni, Amer Assal, Louis Weiss, Ira Braunschweig, Ulrich Steidl, Kith Pradhan, Aditi Shastri, Mark Chaitowitz, Barry Zingman, Britta Will, Ioannis Mantzaris & Amit Verma
Pages: 3529-3535
Published online: 08 Jul 2019
AbstractforHIV portends a poor prognosis in myelodysplastic syndromes | Full Text | References | PDF (1,019.8 KB) | EPUB
  • 367 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years
Qaiser Bashir, Kamal Chamoun, Denái R. Milton, Maliha Khan, Sairah Ahmed, Rohtesh Mehta, Uday R. Popat, Partow Kebriaei, Yago Nieto, Betul Oran, Stefan O. Ciurea, Chitra Hosing, Isa Khouri, Krina Patel, Elisabet E. Manasanch, Hans C. Lee, Robert Z. Orlowski, Richard E. Champlin & Muzaffar H. Qazilbash
Pages: 3536-3543
Published online: 08 Jul 2019
AbstractforOutcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 years | Full Text | References | PDF (769.6 KB) | EPUB
  • 385 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population
Rajshekhar Chakraborty, Lisa Rybicki, Jacqulyn Tomer, Christy J. Samaras, Beth M. Faiman, Jason Valent & Navneet S. Majhail
Pages: 3544-3551
Published online: 05 Jul 2019
AbstractforPatient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world population | Full Text | References | PDF (665.7 KB) | EPUB | Supplemental
  • 221 Views
  • 4 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Increased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiency
Marcia Torresan Delamain, Gabriela Vilas Bôas Gomez, Gustavo Jacob Lourenço, Carmino Antônio de Souza & Carmen Silvia Passos Lima
Pages: 3552-3556
Published online: 08 Jul 2019
First Page PreviewforIncreased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiency | Full Text | References | PDF (1,000.8 KB) | EPUB | Supplemental
  • 59 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia
Erin Hickey, Bryant Clemons, Shawn Griffin, Jessica Cox, Stephanie Sutphin, Reshma Ramlal & Lydia Benitez
Pages: 3557-3560
Published online: 11 Jul 2019
First Page PreviewforMulticenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemia | Full Text | References | PDF (362.7 KB) | EPUB
  • 519 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Peripheral T-cell lymphoma NOS arising in patients with classical Hodgkin lymphoma of cytotoxic phenotype
Katrin S. Huettl, Annette M. Staiger, Alexander Stehle, Irina Bonzheim, Heike Horn, Vanessa Borgmann, Michaela Ott, Falko Fend & German Ott
Pages: 3561-3564
Published online: 10 Jul 2019
First Page PreviewforPeripheral T-cell lymphoma NOS arising in patients with classical Hodgkin lymphoma of cytotoxic phenotype | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 137 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’
Giuseppe Mele, Domenico Pastore, Nicola Di Renzo, Alberto Fragasso, Attilio Guarini, Patrizio Mazza, Pellegrino Musto, Vincenzo Pavone, Giuseppe Tarantini, Paola Curci, Antonietta Pia Falcone, Anna Mele, Maria Rosanna Miccolis, Giulia Palazzo, Gaetano Palumbo, Angela Maria Quinto, Giovanni Reddiconto, Rita Rizzi, Nicola Cascavilla, Giorgina Specchia & Silvana Franca Capalbo
Pages: 3565-3568
Published online: 09 Jul 2019
First Page PreviewforReal world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’ | Full Text | References | PDF (422.6 KB) | EPUB
  • 327 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation
Kah Poh Loh, Andrea Baran, Christina Y. Lee, Alfadel Alshaibani, Sarah C. Rutherford, John Hu, Carla Casulo, Paul M. Barr, Jonathan W. Friedberg & Patrick M. Reagan
Pages: 3569-3572
Published online: 08 Jul 2019
First Page PreviewforPatients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation | Full Text | References | PDF (624.3 KB) | EPUB | Supplemental
  • 214 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor
Patrick-Pascal Strunz, Marc Schmalzing, Anke Heidemeier, Leo Rasche, Hermann Einsele & K. Martin Kortüm
Pages: 3573-3576
Published online: 18 Jul 2019
First Page PreviewforResponse to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donor | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 461 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma
Vu H. Duong, Noa G. Holtzman, Rima Koka, Zeba N. Singh, Ying Zou, Ashkan Emadi, Aaron P. Rapoport, Mehmet H. Kocoglu, Maria R. Baer & Ashraf Z. Badros
Pages: 3577-3580
Published online: 08 Jul 2019
First Page PreviewforCharacteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myeloma | Full Text | References | PDF (393 KB) | EPUB
  • 204 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma
Talal Hilal, Alanna Maguire, Heidi E. Kosiorek, Lisa M. Rimsza & Allison C. Rosenthal
Pages: 3581-3583
Published online: 27 Jun 2019
First Page PreviewforClinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphoma | Full Text | References | PDF (397.2 KB) | EPUB
  • 148 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
‘Secondary chronic myeloid leukemia’: comparison between patients previously exposed or not to chemo- and/or radiotherapy
Francesco Autore, Federica Sorà, Patrizia Chiusolo, Mario Annunziata, Alessandra Iurlo, Daniele Cattaneo, Sara Galimberti, Jolanta Alina Bajer & Simona Sica
Pages: 3584-3586
Published online: 11 Jul 2019
First Page Previewfor‘Secondary chronic myeloid leukemia’: comparison between patients previously exposed or not to chemo- and/or radiotherapy | Full Text | References | PDF (402.5 KB) | EPUB
  • 78 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma
Jun Watanabe, Manabu Natsumeda, Yu Kanemaru, Masayasu Okada, Makoto Oishi, Akiyoshi Kakita & Yukihiko Fujii
Pages: 3587-3589
Published online: 15 Jul 2019
First Page PreviewforComparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphoma | Full Text | References | PDF (749.1 KB) | EPUB
  • 258 Views
  • 15 CrossRef citations
  • 0Altmetric
Letter
Ixazomib-induced Sweet's syndrome
Satoko Oka, Kazuo Ono & Masaharu Nohgawa
Pages: 3590-3591
Published online: 27 Aug 2019
CitationforIxazomib-induced Sweet's syndrome | Full Text | References | PDF (634.6 KB) | EPUB
  • 196 Views
  • 3 CrossRef citations
  • 0Altmetric

Explore articles